- Investing Ideas
- /
- German Biotech Stocks
German Biotech Stocks
Results
19
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
19 companies
Merck KGaA
Market Cap: €47.0b
Operates as a science and technology company in Germany.
MRK
€108.15
7D
0.5%
1Y
-30.2%
Bayer
Market Cap: €27.1b
Operates as a life science company worldwide.
BAYN
€27.61
7D
0.8%
1Y
-3.8%
SCHOTT Pharma KGaA
Market Cap: €3.3b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXP
€22.20
7D
1.8%
1Y
-27.2%
Dermapharm Holding
Market Cap: €1.7b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMP
€32.05
7D
-1.8%
1Y
-3.9%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€6.23
7D
0.2%
1Y
5.6%
PEPTONIC medical
Market Cap: €560.2m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
28L
€0.0002
7D
0%
1Y
0%
Formycon
Market Cap: €411.6m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€23.30
7D
3.8%
1Y
-52.9%
PharmaSGP Holding
Market Cap: €352.3m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€30.60
7D
3.4%
1Y
n/a
Darwin
Market Cap: €96.0m
Operates as a biotechnology company.
7V0
€8.00
7D
36.8%
1Y
26.0%
Apontis Pharma
Market Cap: €91.2m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€10.95
7D
0.5%
1Y
67.9%
MPH Health Care
Market Cap: €80.3m
An investment company, engages in the healthcare business in Germany.
93M1
€18.85
7D
1.1%
1Y
-22.7%
2invest
Market Cap: €74.4m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€13.50
7D
10.7%
1Y
28.6%
Genetic Analysis
Market Cap: €56.7m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
8V8
€0.057
7D
1.8%
1Y
33.9%
Cantourage Group
Market Cap: €42.3m
Operates as a medical cannabis company in Europe.
HIGH
€3.39
7D
-7.9%
1Y
-32.9%
Respiratorius
Market Cap: €19.9m
A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.
HF00
€0.22
7D
-16.3%
1Y
-16.9%
Biofrontera
Market Cap: €16.7m
A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
B8FK
€2.75
7D
1.5%
1Y
20.1%
Medigene
Market Cap: €985.6k
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.069
7D
4.5%
1Y
-96.6%
Cannovum Cannabis
Market Cap: €808.9k
Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.
27N0
€0.35
7D
-5.4%
1Y
-63.9%
Sangui Biotech International
Market Cap: €419.8k
Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.
SBH
€0.002
7D
0%
1Y
-77.8%